Radius Health CEO Hoeiland Steps Down, Martin Named Successor

Radius Health (NASDAQ: [[ticker:RDUS]]) president and CEO Jesper Hoeiland has stepped down, the company announced Tuesday. In a statement, Hoeiland said that after nearly 25 years abroad, he and his wife decided to return to Denmark to be closer to family and friends. According to a securities filing, he will serve as a paid advisor to the Waltham, MA-based company through Oct. 28. Hoeiland joined Radius in 2017, two months after the company won FDA approval for abaloparatide (Tymlos), a biologic treatment for osteoporosis.

Kelly Martin has been appointed Radius’s new president and CEO. He has also joined the company’s board of directors. Martin was most recently CEO of Novan (NASDAQ: [[ticker:NOVN]]). His experience also includes CEO posts at Malin and Elan Pharmaceuticals.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan